Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis

Tubercle and Lung Disease

Volumn 79, Issue 2, 1998, Pages 83-89

  Bellamy, R ^a   Ruwende, C ^a   Corrah, T ^b   McAdam, K P W J ^b   Whittle, H C ^b   Hill, A V S ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

[No Author keywords available]

Indexed keywords

FUCOSYLTRANSFERASE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BLOOD DONOR; CHROMOSOME 2; CONTROLLED STUDY; DNA BASE COMPOSITION; DNA POLYMORPHISM; FEMALE; GAMBIA; GENE CLUSTER; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HOST SUSCEPTIBILITY; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; PRIORITY JOURNAL;

EID: 0032462235     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1054/tuld.1998.0009     Document Type: Article

References (38)

1. 1. Dolin P J, Raviglione M C, Kochi A. Global tuberculosis and mortality during 1990-2000. Bull World Health Organ 1994; 72: 213-220.
2. 2. Murray C J L, Styblo K, Rouillon A. Tuberculosis in developing countries: burden, intervention and cost. Bulletin of the International Union Against Tubercle and Lung Disease 1990; 65: 6-24.
3. 3. Bellamy R. Genetic susceptibility to tuberculosis in human populations. Thorax (in press).
4. 4. Comstock G W. Tuberculosis in twins: a re-analysis of the Prophit study. Am Rev Respir Dis 1978; 117: 621-624.
5. 5. Kallmann F J, Reisner D. Twin studies on the significance of genetic factors in tuberculosis. Am Rev Tuberc 1942; 47: 549-574.
6. 6. Hill A V S. Genetics of infectious disease resistance. Curr Opin Genet Dev 1996; 6: 348-353.
7. 7. Brahmajothi V, Pitchappan R M, Kakkanaiah V N et al. Association of tuberculosis and HLA in South India. Tubercle 1991; 72: 123-132.
8. 8. Bothamley G H, Beck J S, Schraeder G M T et al. Association of tuberculosis and M. tuberculosis-specific antibody levels with HLA. J Infect Dis 1989; 159: 549-555.
9. 9. Singh S P N, Mehra N K, Dingley H B, Pande J N, Vaidya M C. Human leukocyte antigen (HLA)-linked control of susceptibility to tuberculosis and association with HLA-DR types. J Infect Dis 1983; 148: 676-681.
10. 10. Bellamy R, Ruwende C, Corrah T, McAdam K P W J, Whittle H C, Hill A V S. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998; 338: 640-644.
11. 11. Fenton M J, Vermeulen M W. Immunopathology of tuberculosis: roles of macrophages and monocytes. Infect Immun 1996; 64: 683-690.
12. 12. Dinarello C A. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627-1652.
13. 13. Dinarello C A, Thompson R C. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today 1991; 12: 404-410.
14. 14. Nicklin M J H, Weith A, Duff G W. A physical map of the region encompassing the human interleukin-1α, interleukin-1β, and interleukin-1 receptor antagonist genes. Genomics 1994; 19: 382-384.
15. 15. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991; 174: 1549-1555.
16. 16. Henry S, Oriol R, Samuelsson B. Lewis histo-blood group system and associated secretory phenotypes. Vox Sang 1995; 69: 166-182.
17. 17. Kelly R J, Rouquier S, Giorgi D, Lennon G G, Lowe J B. Sequence and expression of a candidate for the human secretor blood group alpha(1,2) fucosyltransferase gene (FUT2). J Biol Chem 1995; 270: 4640-4649.
18. 18. Blackwell C C, Weir D M, James V S, Cartwright K A V, Stuart J M, Jones D M. The Stonehouse study: secretor status and carriage of Neisseria species. Epidemiol Infect 1989; 102: 1-10.
19. 19. Raza M W, Blackwell C C, Molyneaux P et al. Association between secretor status and respiratory viral illness. BMJ 1991; 303: 815-818.
20. 20. Blackwell C C, James V S, Davidson S et al. Secretor status and heterosexual transmission of HIV. BMJ 1991; 303: 825-826.
21. 21. Thom S M, Blackwell C C, MacCallum C J et al. Nonsecretion of blood group antigens and susceptibility to infection by Candida species. FEMS Microbiol 1989; 47: 401-406.
22. 22. Zopf D, Roth S. Oligosaccharide anti-infective agents. Lancet 1996; 347: 1017-1021.
23. 23. Schlesinger L S. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J Immunol 1993; 150: 2920-2930.
24. 24. Allsopp C E M, Harding R H, Taylor C et al. Interethnic genetic differentiation in Africa: HLA class I antigens in The Gambia. Am J Hum Genet 1992; 50: 411-421.
25. 25. Epplen C, Frank G, Gomolka M, Albert E, Nurnberg P, Epplen J T. Dinucleotide repeat polymorphism in the human IL1A gene. Hum Mol Genet 1994; 3: 1710.
26. 26. Eskdale J, Gallagher G. A polymorphic dinucleotide repeat in the human IL-10 promoter. Immunogenetics 1995; 42: 444-445.
27. 27. Turner D M, Williams D M, Sankaran D, Lazarus D, Sinnott P J, Hutchinson I V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8.
28. 28. Di Giovine F S, Takhsh E, Blakemore A I F, Duff G W. Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1beta). Hum Mol Genet 1992; 1: 450.
29. 29. Tarlow J K, Blakemore A I F, Lennard A et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993; 91: 403-404.
30. 30. Reed P W, Davies J L, Copeman J B et al. Chromosome-specific microsatellite sets for fluorescence-based, semi-automated genome mapping. Nature Genet 1994; 7: 390-395.
31. 31. Clark B D, Collins K L, Gandy M S, Webb A C, Auron P E. Genomic sequence for human prointerleukin 1 beta: possible evolution from a reverse transcribed prointerleukin 1 alpha gene. Nucleic Acids Res 1986; 14: 7897-7914.
32. 32. Clay F E, Cork M J, Tarlow J K et al. Interleukin 1 receptor antagonist polymorphism association with lichen sclerosus. Hum Genet 1994; 94: 407-410.
33. 33. Mansfield J C, Holden H, Tarlow J K et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994; 106: 637-642.
34. 34. Blakemore A I, Tarlow J K, Cork M J, Gordon C, Emery P, Duff G W. Interleukin 1 receptor antagonist gene polymorphism as a disease factor in systemic lupus erythematosus. Arthritis Rheum 1994; 37: 1380-1385.
35. 35. Blakemore A I, Watson P F, Weetman A P, Duff G W. Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab 1995; 80: 111-115.
36. 36. Crusius J B A, Pena A S, van Oosten B W et al. Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis. Lancet 1995; 346: 979-980 (Letter).
37. 37. Danis V A, Millington M, Hyland V J, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1RA) gene polymorphism. Clin Exp Immunol 1995; 99: 303-310.
38. 38. Kube D, Platzer C, von Knethen A et al. Isolation of the human interleukin 10 promoter. Characterisation of the promoter activity in Burkitt's lymphoma cell lines. Cytokine 1995; 7: 1-7.